On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Gregory A. Otterson

ResearcherPublications, citations & collaboration network

Gregory A. Otterson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Gregory A. Otterson have?

ScholarIQindexed works

Gregory A. Otterson has 440 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Gregory A. Otterson have?

ScholarIQcitation count

Gregory A. Otterson has 30,977 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Gregory A. Otterson?

ScholarIQh-index

Gregory A. Otterson has an h-index of 79 in OpenAlex.

What is the i10-index of Gregory A. Otterson?

ScholarIQi10-index

Gregory A. Otterson has an i10-index of 205 in OpenAlex.

What is the ORCID of Gregory A. Otterson?

ScholarIQorcid

The ORCID for Gregory A. Otterson is on the source record.

What is the OpenAlex record for Gregory A. Otterson?

ScholarIQopenalex

The OpenAlex for Gregory A. Otterson is on the source record.

What are the most-cited papers on Gregory A. Otterson?

ScholarIQmost cited works
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański, Jong Seok Lee, Gregory A. Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak A. Burgers, Pamela Salman, Hossein Borghaei, Suresh S. Ramalingam, Julie R. Brahmer, Martin Reck, Kenneth J. O’Byrne, William J. Geese, George Green, Chang Han, Joseph D. Szustakowski, Prabhu Bhagavatheeswaran, Diane Healey, Yali Fu, Faith E. Nathan, Luis Paz‐Ares
New England Journal of Medicine. 20183,158 CitationsOPEN ACCESS
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20221,440 Citations
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi, Julien Mazières, David Planchard, Thomas E. Stinchcombe, Grace K. Dy, Scott Antonia, Leora Horn, H. Léna, Elisa Minenza, B. Mennecier, Gregory A. Otterson, Luis T. Campos, David R. Gandara, Benjamin Levy, Suresh Nair, Gérard Zalcman, Jürgen Wolf, Pierre‐Jean Souquet, Editta Baldini, Federico Cappuzzo, C. Chouaïd, Afshin Dowlati, Rachel E. Sanborn, Ariel López-Chávez, Christian Grohé, Rudolf M. Huber, Christopher Harbison, Christine Baudelet, Brian Lestini, Suresh S. Ramalingam
The Lancet Oncology. 20151,434 Citations
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20211,015 CitationsOPEN ACCESS
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Scott Gettinger, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, OCN, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20191,007 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account